AM

Adam Muzikant

Chief Business Officer

Avilar Therapeutics

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Avilar Therapeutics
Industry
biotechnology
Employees
28.0
Seniority
C suite
Annual Revenue
1000000.0
Total Funding
75000000.0
Latest Funding
Seed

Professional Summary

Adam Muzikant serves as Chief Business Officer at Avilar Therapeutics. Avilar Therapeutics operates in the biotechnology sector with approximately 28.0 employees. The company is headquartered in Boston, Massachusetts. Avilar Therapeutics generates annual revenue of 1000000.0. To date, Avilar Therapeutics has raised 75000000.0 in total funding, with the most recent round being Seed.

Industry & Role Insights

  • MessageCEO tracks 381 executives in the biotechnology sector.
  • 3,781 executive contacts are available in Massachusetts.
  • Our database includes 201,469 c suite-level executives.

Technologies

Nginx Bootstrap Framework WordPress.org Google Tag Manager Mobile Friendly Vimeo Render Remote Basis AI

Keywords

extracellular protein degradation targeted protein degradation asgpr targeting chimeras atac platform mtac platform biopharmaceutical development modular drug discovery pathogenic proteins protein degrader therapeutics endolysosome targeting hepatocyte internalization disease-causing proteins novel protein degraders drug discovery platform extra-cellular proteome bioinformatics in drug design protein ligand technology asgpr ligands m6pr receptor targeting first-in-class therapeutics immunology applications neurological disease treatments autoimmune therapies drug efficacy enhancement modular design for degraders patent protected technologies high affinity ligands target selection methodologies biophysical modeling in pharmacology drug development strategies therapeutic innovation protein pharmacokinetics advanced drug formulations clinical application of degraders pharmacological interactions biochemical pathways in medicine translational medicine advances medicinal chemistry innovations team of expert scientists scientific advisory excellence healthcare financing in biotech investor engagement in pharmaceuticals regulatory compliance in drug development scientific research advancements collaborative drug discovery market opportunities for biotech integrated healthcare solutions novel therapeutic pipelines

Related Executives

CB
Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio
JL
Jason Loveridge CEO at 4SC AG
MM
Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant
JR
Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.
CH
Chris Harano President and CEO at Advanced BioCatalytics

Frequently Asked Questions

How can I contact Adam Muzikant?

Adam Muzikant's verified email address is available on MessageCEO. They currently work at Avilar Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Adam Muzikant lead?

Adam Muzikant is Chief Business Officer at Avilar Therapeutics, a company in the biotechnology sector with 28.0 employees. The company is based in Boston, Massachusetts.

What industry is Adam Muzikant in?

Adam Muzikant works in the biotechnology industry as Chief Business Officer at Avilar Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Adam Muzikant's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Adam Muzikant's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 18, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans